Related Experiment Video
Updated: Feb 25, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Expression of β-adrenergic receptor subtypes in human normal and dilated ureter
Hailin Shen1, Zhipeng Chen2, Al-Dhabi Mokhtar1
1Department of Urology, The First Affiliated Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, China.
Background:
Ureter peristalsis is a basic physiological function regulated by myogenic and neurogenic factors. The distribution and function of β-adrenergic receptors (β-AR) in the human ureter remain unknown. The aim of this study was to investigate the expression of β-AR subtypes in the normal and dilated human ureter.
Methods:
The upper, middle, and lower segments of normal and dilated ureters were collected from patients undergoing surgery for carcinoma of the kidney and upper urinary tract and ureteral stenosis. The mucosa and muscular layers were separated. Expression of β1-AR, β2-AR, and β3-AR mRNA and protein levels were detected by real-time PCR, western blot, and immunohistochemistry.
Results:
In both mucosa and muscular layers, the mRNA and protein expressions of β1-AR, β2-AR, and β3-AR were lower in the dilated ureter compared with the normal ureter. β1-AR mRNA was significantly decreased (by 76.64%; P < 0.01) in the mucosa layer of the middle segment of the dilated ureter. β1-AR and β3-AR mRNA were significantly decreased (by 75.53 and 53.62%, respectively; P < 0.01) in the muscular layer of the lower segment of the dilated ureter. Similar findings were observed for protein expression.
Conclusions:
The downregulation of β-ARs after ureter dilation, particularly for β1-AR and β3-AR in the muscular layer, suggests a potential compensatory mechanism involving increased contraction of the ureter to push urine through the obstruction. Thus, β-ARs may be a potential target for treatment of ureter obstruction.
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
Antihypertensive Drugs: Action of β1 Blockers
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Antihypertensive Drugs: Types of β-Blockers

